NO20005062L - Behandling av panikkanfall - Google Patents

Behandling av panikkanfall

Info

Publication number
NO20005062L
NO20005062L NO20005062A NO20005062A NO20005062L NO 20005062 L NO20005062 L NO 20005062L NO 20005062 A NO20005062 A NO 20005062A NO 20005062 A NO20005062 A NO 20005062A NO 20005062 L NO20005062 L NO 20005062L
Authority
NO
Norway
Prior art keywords
panic attacks
treatment
panic
attacks
isobenzo
Prior art date
Application number
NO20005062A
Other languages
English (en)
Other versions
NO20005062D0 (no
Inventor
Connie Sanchez
Sandra Hogg
Maria Jessa
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20005062D0 publication Critical patent/NO20005062D0/no
Publication of NO20005062L publication Critical patent/NO20005062L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

BForbindelsen l'-[4-[l-(4-fluorfenyl)-ln-indol-3-yl]-1-butyl]- spiro[isobenzo-furan-l (3H) ,4'-piperidin] er aktiv i modeller som forutsier effekt på panikkanfall og kan anvendes for fremstil- lingen av et medikament for behandling av sykdommer forbundet med panikkanfall.
NO20005062A 1998-04-07 2000-10-06 Behandling av panikkanfall NO20005062L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK50198 1998-04-07
PCT/DK1999/000190 WO1999051229A1 (en) 1998-04-07 1999-03-30 Treatment of panic attacks

Publications (2)

Publication Number Publication Date
NO20005062D0 NO20005062D0 (no) 2000-10-06
NO20005062L true NO20005062L (no) 2000-11-30

Family

ID=8094284

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005062A NO20005062L (no) 1998-04-07 2000-10-06 Behandling av panikkanfall

Country Status (23)

Country Link
US (1) US6262061B1 (no)
EP (1) EP1069899A1 (no)
JP (1) JP2002510626A (no)
KR (1) KR20010042502A (no)
CN (1) CN1296409A (no)
AR (1) AR019023A1 (no)
AU (1) AU3025899A (no)
BG (1) BG104814A (no)
BR (1) BR9909598A (no)
CA (1) CA2325948A1 (no)
EA (1) EA200001032A1 (no)
HR (1) HRP20000659A2 (no)
HU (1) HUP0101706A3 (no)
ID (1) ID28335A (no)
IL (1) IL138484A0 (no)
IS (1) IS5636A (no)
NO (1) NO20005062L (no)
PL (1) PL342989A1 (no)
SK (1) SK14842000A3 (no)
TR (1) TR200002891T2 (no)
WO (1) WO1999051229A1 (no)
YU (1) YU58900A (no)
ZA (1) ZA200004856B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU18701A (sh) * 1998-09-15 2003-07-07 H. Lundbeck A/S. Tretiranje depresije
AR030453A1 (es) * 2000-08-15 2003-08-20 Lundbeck & Co As H Composicion farmaceutica con contenido de 1' [4-[1-(4-fluorofenil)-1h-indol-3-il]-1-butil] espiro [isobenzofuran-1 (3h), 4'-piperidina]
WO2004110388A2 (en) * 2003-06-12 2004-12-23 Agy Therapeutics, Inc. Sigma ligands for neuronal regeneration and functional recovery

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
EA200001032A1 (ru) 2001-04-23
IL138484A0 (en) 2001-10-31
WO1999051229A1 (en) 1999-10-14
AR019023A1 (es) 2001-12-26
YU58900A (sh) 2002-11-15
CA2325948A1 (en) 1999-10-14
HUP0101706A3 (en) 2003-03-28
KR20010042502A (ko) 2001-05-25
TR200002891T2 (tr) 2001-02-21
JP2002510626A (ja) 2002-04-09
NO20005062D0 (no) 2000-10-06
BR9909598A (pt) 2000-11-21
AU3025899A (en) 1999-10-25
US6262061B1 (en) 2001-07-17
BG104814A (en) 2001-04-30
IS5636A (is) 2000-09-22
CN1296409A (zh) 2001-05-23
HRP20000659A2 (en) 2001-04-30
ID28335A (id) 2001-05-10
HUP0101706A2 (hu) 2001-11-28
PL342989A1 (en) 2001-07-16
ZA200004856B (en) 2001-08-29
EP1069899A1 (en) 2001-01-24
SK14842000A3 (sk) 2001-06-11

Similar Documents

Publication Publication Date Title
WO2003077972A3 (en) Implantable drug delivery system
ES2067939T3 (es) Sistema de distribucion de un medicamento iontoforetico con un perfil de reparto de dos etapas.
CY1115583T1 (el) Σκευασμα που περιλαμβανει μεταλλαγμα/τα της λυσοσωμικης αλφα-γαλακτοσιδασης α για τη θεραπευτικη αντιμετωπιση της νοσου fabry
ATE154239T1 (de) Sphäroidische arzneimittelformulierung
CA2149636A1 (en) Method of activating photosensitive agents
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
AU2002241719A1 (en) Therapy management techniques for an implantable medical device
DE69331605D1 (de) Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
NO20101070L (no) Fremgangsmate til dosering av et medikament, samt doseringsform
AU4409489A (en) Animal model for diagnosing and testing vaccines or therapeutic agents against aids
TR200001267T2 (tr) 1'-[4-Florofenil)-1H-Indol-3-İl] -1-Bütil1-Spiro[izobenzofüran- 1(3H), 4'-Piperidin] hidrohalojenitler
NO20005062L (no) Behandling av panikkanfall
NO982863L (no) Nye forbindelser med analgetisk effekt
CA2097182A1 (en) Method and device for treating tobacco addiction
NO20011268L (no) Forbindelse til behandling av depresjon
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
ES2053834T3 (es) Un metodo para la preparacion de una sustancia terapeutica.
Malec et al. A clinical trial of the combination of L-tryptophan and lithium in the treatment of chronic alcoholism.
UA49165A (uk) Спосіб лікування фонових процесів шийки матки хламідійної етіології
UA31474A (uk) Спосіб зняття потягу до алкоголю
HUP9701558A2 (hu) Spiro{furo[2,3-f]indol-3,4'-piperidin}-származék, eljárás előállítására, alkalmazása és az ezt tartalmazó gyógyszerkészítmények
UA33946A (uk) Спосіб лікування алкогольної хвороби печінки
NO20082302L (no) Anvendelse av et pleuromutilinderivat innen vetrinaermedisin samt fremgangsmate for fremstilling av et medikament omfattende forbindelsen
DE3781638D1 (de) Tetrazolylchinazolinone als mittel gegen hyperurikaemie.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application